Forskolin promotes vasculogenic mimicry and invasion via Notch‑1‑activated epithelial‑to‑mesenchymal transition in syncytiolization of trophoblast cells in choriocarcinoma.


Journal

International journal of oncology
ISSN: 1791-2423
Titre abrégé: Int J Oncol
Pays: Greece
ID NLM: 9306042

Informations de publication

Date de publication:
05 2020
Historique:
received: 01 07 2019
accepted: 23 01 2020
pubmed: 23 4 2020
medline: 9 2 2021
entrez: 23 4 2020
Statut: ppublish

Résumé

Choriocarcinoma (CC) is characterized by earlier blood metastasis compared with other female genital tumors and a high incidence of massive hemorrhage. Vasculogenic mimicry (VM) is highly associated with metastasis, and syncytiotrophoblast is involved in the formation of VM in CC. Forskolin is a typical activator of the cAMP pathway, which is involved in the syncytiolization of trophoblastic cells. In the present study, to determine the effects and mechanism of forskolin on cell invasion and VM during syncytiolization in vitro and in vivo, JEG‑3 and JAR cell lines were treated with 100 µM forskolin for 48 h, and wound healing and invasion assays were used to verify cell migratory and invasive capacities. A 3D culture and tube formation assays were established to detect VM. Variation of morphology and markers of the epithelial‑to‑mesenchymal transition (EMT) were assessed, and the role of the Notch signaling pathway was investigated in CC cells treated with forskolin. The results of the present study demonstrated that 100 µM forskolin induced syncytiolization of trophoblastic cells and enhanced the migratory and invasive abilities of JEG‑3 and JAR cell lines. In addition, the capacity of VM was significantly increased, whereas tube formation ability was decreased by forskolin in vitro and in vivo compared with the respective control groups. The cellular morphology exhibited EMT during the syncytiolization process, which was further supported by the changes in EMT marker expression, including downregulation of E‑cadherin and cytokeratin and upregulation of N‑cadherin, vimentin and zinc finger E‑box‑binding homeobox 1. The Notch‑1 signaling pathway was activated to induce EMT in forskolin‑induced VM process in CC cells, and VM and EMT could be reversed by using the γ‑secretase inhibitor DAPT to block the Notch‑1 pathway. Overall, the results of the present study demonstrated that forskolin enhanced the capacity of VM formation and metastasis through Notch‑1‑activated EMT in the syncytiolization of trophoblastic cells.

Identifiants

pubmed: 32319581
doi: 10.3892/ijo.2020.4997
pmc: PMC7115352
doi:

Substances chimiques

NOTCH1 protein, human 0
Receptor, Notch1 0
Colforsin 1F7A44V6OU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1129-1139

Références

Mod Pathol. 2011 May;24(5):646-52
pubmed: 21217646
Nat Rev Cancer. 2003 Jun;3(6):411-21
pubmed: 12778131
Cell. 2010 Apr 2;141(1):52-67
pubmed: 20371345
J BUON. 2016 May-Jun;21(3):533-41
pubmed: 27569069
Pharmacol Ther. 2015 Jun;150:33-46
pubmed: 25595324
BMC Cancer. 2011 Jul 18;11:301
pubmed: 21767374
Early Pregnancy. 1995 Dec;1(4):263-9
pubmed: 9363258
Reprod Biol Endocrinol. 2009 Nov 25;7:135
pubmed: 19939245
Cochrane Database Syst Rev. 2012 Dec 12;12:CD008891
pubmed: 23235667
Endocrinology. 2006 Sep;147(9):4112-21
pubmed: 16740972
Hepatology. 2010 Feb;51(2):545-56
pubmed: 19957372
Mol Cell Endocrinol. 2001 Sep;182(2):215-24
pubmed: 11514056
Sci Rep. 2016 Mar 16;6:23091
pubmed: 26980408
Life Sci. 2008 Jun 20;82(25-26):1272-80
pubmed: 18538351
Mol Cancer. 2014 Sep 08;13:207
pubmed: 25200065
J Clin Invest. 2009 Jun;119(6):1420-8
pubmed: 19487818
Cancer Sci. 2012 Apr;103(4):813-20
pubmed: 22212097
Bioessays. 2004 Mar;26(3):225-34
pubmed: 14988924
Angiogenesis. 2017 Nov;20(4):409-426
pubmed: 28660302
Reprod Biol Endocrinol. 2004 Aug 04;2:59
pubmed: 15294019
Geburtshilfe Frauenheilkd. 2015 Oct;75(10):1043-1050
pubmed: 26556906
Placenta. 1999 Sep;20(7):547-53
pubmed: 10452908
J Cell Sci. 1998 Apr;111 ( Pt 7):995-1004
pubmed: 9490643
Clin Exp Med. 2013 Aug;13(3):201-9
pubmed: 22627943
BMC Cell Biol. 2010 Sep 07;11:68
pubmed: 20822540
Am J Pathol. 1999 Sep;155(3):739-52
pubmed: 10487832
Reproduction. 2014 Feb 04;147(3):R75-86
pubmed: 24357662
J Cell Mol Med. 2015 Feb;19(2):315-26
pubmed: 25598425
Placenta. 2017 Aug;56:65-72
pubmed: 28117145
Reprod Biol Endocrinol. 2005 Oct 20;3:56
pubmed: 16236179
J Cell Biol. 2006 Mar 27;172(7):973-81
pubmed: 16567498
J Natl Compr Canc Netw. 2019 Nov 1;17(11):1374-1391
pubmed: 31693991
Oncol Rep. 2015 Nov;34(5):2395-402
pubmed: 26479853
Placenta. 2016 Mar;39:116-24
pubmed: 26992684
J Clin Invest. 2004 Sep;114(6):744-54
pubmed: 15372095
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Int J Oncol. 2015 Aug;47(2):728-38
pubmed: 26094772
Oncotarget. 2016 Apr 26;7(17):24050-62
pubmed: 26992227
Neuro Endocrinol Lett. 2012;33(4):406-11
pubmed: 22936257
Mol Reprod Dev. 2008 Jan;75(1):175-83
pubmed: 17546632
Cancer Biol Ther. 2006 Feb;5(2):228-33
pubmed: 16481735
Arterioscler Thromb Vasc Biol. 2006 Sep;26(9):1977-84
pubmed: 16809546
J Biol Chem. 1996 Mar 8;271(10):5914-20
pubmed: 8621465
Cell Stem Cell. 2018 Jan 4;22(1):50-63.e6
pubmed: 29249463
Nature. 2000 Jun 22;405(6789):966-70
pubmed: 10879540
Oncol Lett. 2013 Nov;6(5):1174-1180
pubmed: 24179490
Mol Cell Endocrinol. 2002 Feb 22;187(1-2):207-12
pubmed: 11988329
Biochim Biophys Acta. 2010 Aug;1806(1):18-28
pubmed: 20079807

Auteurs

Yan Xue (Y)

Department of Gynecology and Obstetrics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.

Rong Sun (R)

Department of Gynecology and Obstetrics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.

Wei Zheng (W)

Department of Gynecology and Obstetrics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.

Lei Yang (L)

Department of Gynecology and Obstetrics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.

Ruifang An (R)

Department of Gynecology and Obstetrics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH